Bill Title: To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
Spectrum: Partisan Bill (Republican 17-0)
Status: (Introduced) 2025-01-23 - Referred to the House Committee on Energy and Commerce.
[HB679 Detail]
Bill Drafts
Revision | Date | Format | Source | View |
Introduced | 2025-02-21 | PDF | Link | View |
Amendments
Amendment | Date | Disposition | Format | Source | View |
No bill amendments currently on file for US Congress HB679 |
Supplemental Documents
Title | Description | Date | Format | Source | View |
No supplemental documents for US Congress HB679 currently on file. |
Social Comments on US HB679